Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Loss of Thyroid Hormone Transporters MCT8 and OATP1C1 in Mouse Oligodendroglia Cells Results in a Delayed Oligodendrocyte Maturation and Myelination.

Thyroid : official journal of the American Thyroid Association·2026
Same author

A rare missense variant impacting NEK1 kinase function is associated with ALS.

Acta neuropathologica communications·2026
Same author

Triiodothyroacetic acid exerts tissue-specific thyromimetic effects without tachycardia and hyperthermia in male mice.

European thyroid journal·2026
Same author

Culture-specific transcriptional drifts limit the fidelity of organoid infection models.

PLoS pathogens·2026
Same author

Pregnancy negates thyroid hormone-induced pyrexia.

American journal of physiology. Endocrinology and metabolism·2026
Same author

<i>THRB</i> splice site variants lead to exon 4 skipping and TRβ1 gain-of-function syndrome.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: May 28, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

TSH compensates thyroid-specific IGF-I receptor knockout and causes papillary thyroid hyperplasia.

Kathrin Müller1, Dagmar Führer, Jens Mittag

  • 1Department of Internal Medicine, University of Leipzig, Germany.

Molecular Endocrinology (Baltimore, Md.)
|October 8, 2011
PubMed
Summary

Inactivating the Insulin-like Growth Factor I Receptor (IGF-IR) in mice thyroids increased Thyroid Stimulating Hormone (TSH) and caused papillary hyperplasia. TSH fully compensated for IGF-IR loss in thyroid hormone synthesis.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Related Experiment Videos

Last Updated: May 28, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Thyroid Research

Background:

  • Thyroid physiology is primarily stimulated by TSH.
  • IGF-I receptor (IGF-IR) signaling plays a permissive role in TSH action.
  • The specific in vivo role of IGF-IR in thyroid function requires further investigation.

Purpose of the Study:

  • To investigate the in vivo importance of IGF-IR in thyroid physiology.
  • To understand the impact of targeted Igf1r inactivation on thyroid function and morphology.

Main Methods:

  • Utilized a Cre-lox system for targeted inactivation of the Igf1r gene in mouse thyroids.
  • Studied mice with wild-type, heterozygous (Igf1r(+/-)), and homozygous (Igf1r(-/-)) genotypes.
  • Analyzed thyroid hormone levels, TSH levels, thyroid weight, histology, and gene/protein expression.

Main Results:

  • Targeted Igf1r inactivation led to transiently reduced thyroid hormones and significantly increased TSH levels.
  • Histological analysis revealed thyroid hyperplasia, heterogeneous follicle structure, and papillary thyroid architecture in Igf1r-inactivated mice.
  • Observed increased body weight in male homozygous mice and altered mRNA/protein levels for thyroid peroxidase and IGF-II receptor.

Conclusions:

  • Elevated TSH levels compensate for the loss of IGF-IR signaling regarding thyroid hormone synthesis.
  • IGF-IR signaling appears less critical for thyroid hormone synthesis but essential for maintaining thyroid homeostasis and normal morphogenesis.
  • Thyroid-specific Igf1r inactivation results in papillary hyperplasia, suggesting a role for IGF-IR in regulating thyroid cell proliferation and structure.